Serial Number:
79027965
Mark:
AFFISORB
Status:
Status Date:
11-13-2015
Filing Date:
Registration Number:
3602579
Registration Date:
04-07-2009
Pharmaceutical preparations designed to remove pathological molecules from the blood for therapy and prophylaxis of medical conditions, namely, Alzheimer disease and arteriosclerosis and other cardio-vascular diseases; chemical preparations for pharmaceutical and medical purposes, namely, peptide based substances for use in the treatment of Alzheimer disease and arteriosclerosis and other cardio-vascular diseases; vaccines, diagnostic preparations for medical purposes, chemical reagents for medical and veterinary purposes, namely, for treatment and diagnosis of Alzheimer disease and arteriosclerosis and other cardio-vascular diseases; chemical and biological substances for medical use, namely, for Alzheimer disease and arteriosclerosis and other cardio-vascular diseases Chemical preparations for use in medical research, science and laboratories; biological preparations in the nature of molecules for use in medical research, science and laboratories for purposes of research, analysis and diagnostics, namely, biological reagents known as probes for detecting and analyzing molecules in proteins or nucleotide arrays Medical instruments and apparatus as well as replacement parts of the aforementioned goods, namely, instruments and apparatus used in blood analysis and for removing pathological molecules from the blood for use in therapy and prophylaxis of medical conditions, namely, blood filters, blood component separation apparatus Development of medical diagnostic, therapy and test methods, namely, conducing clinical trials and scientific investigations for medical purposes, research in the field of chemical medicine, pharmaceutics and bacteriology
Mark Description:
N/A
Class:
Scientific and technological services
Type of Mark:
Trademark
Published for Opposition Date:
01-20-2009
Owner:
Mark Drawing Status:
Standart Character Mark
Abandon Date:
N/A
Business Name:
SALISBURY SQUARE HOUSE,
Correspondent Name: